NCT06013033View on ClinicalTrials.gov

DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation

Not yet recruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

SepsisSeptic Shock

All Listed Sponsors

lead

Zhongda Hospital

OTHER

NCT06013033 - DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation | Biotech Hunter | Biotech Hunter